1/21/2022 | 3004902400 | XTANDI (ENZALUTAMIDA), S/M, S/M LOT T038164 - 0001227219 // STOCKED LOT PA2095322 // EXPIRES 30-APR-2023 PROTOCOL MK-3475-991 // (81008424) BOTTLE CONTAINING 120 SOFT CAPSULES. ORALLY // 40MG RD 2395-2020-DIGEMID/DPF/AESC/MINSA, 24-APR-2020,RD 117-20 | 3.62 | KG | 177332.192 | Peru | MIAMI LAKES | WORLD COURER INC | Get Detailed Shipment Records
|
1/18/2022 | 3004902400 | O-ACETYLSALICYLIC ACID; ALUMINUM O-ACETYSALICYLATE; METHYL SALICYLATE; | 30 | Unit (Each) | 493.5 | Uruguay | | |
1/24/2022 | 3004902400 | O-ACETYLSALICYLIC ACID; ALUMINUM O-ACETYSALICYLATE; METHYL SALICYLATE; | 18 | Unit (Each) | 296.1 | Uruguay | | |
1/27/2022 | 3004902400 | S/MS/M MEDICATION ENTRECTINIB 200 MG ONCOLOGICAL MEDICATION FOR HUMAN USE FOR THE TREATMENT OF CANCER BOTTLE (CONTAINER) WITH 30 CAPSULES ORAL VIAL CLINICAL STUDY PROTOCOL BO29554 RO 710-2122/F14-04, 30 CAPSULES ENTRECINIB 200 MG LOT: GEX0288, eleven | 0.97 | KG | 9283.964 | Peru | BASEL | F. HOFFMANN-LA ROCHE AG |
1/17/2022 | 3004902400 | ASPARAGINASE,ONCASPAR,S/M, MEDICINE FOR ONCOLOGICAL USE LOT N°: 1236K ONCASPAR 3,750 I/U, 1 VIAL EXPIRY DATE: 02/29/2024 | 9.8 | KG | 6844.523 | Peru | FRANKFURT MAIN | KOMTUR PHARMACEUTICALS |
1/17/2022 | 3004902400 | ASPARAGINASE,ONCASPAR,S/M, MEDICINE FOR ONCOLOGICAL USE LOT N°: 1236K ONCASPAR 3,750 I/U, 1 VIAL EXPIRY DATE: 02/29/2024 | 9.2 | KG | 8454.497 | Peru | FRANKFURT MAIN | KOMTUR PHARMACEUTICALS |
1/20/2022 | 3004902400 | XTANDI 40MG, XTANDI, S/M ONCOLOGY/ACTIVE PRINCIPLE: ENZALUTAMIDE; LOT: 1881288AC, EXP.: 08/30/23 DRUG FOR HUMAN USE, IN COLORLESS PVC/PCTFE-ALUMINUM BLISTER FOR 4 WHITE CAPSULES SOFT CAPSULES; XTANDI 40MG 120CAP (POUCH) 901899 | 169.29 | KG | 298187.85 | Peru | PANAMA CITY | ADIUM PHARMA SA |
1/21/2022 | 3004902400 | MEDICAMENTO, ARIMIDEX, S / M CODE: 2703905XPE // LOT: RY555 // MANU .: 01.03.2021 F. DE EXPIRA .: 28.02.2026 PRESENT. IN CARTON BOXES OF 28 BLISTER ARIMIDEX 1MG TABS 2X14S XPE ONCOLOGICAL MEDICINE, ACTIVE INGREDIENT: ANASTROZOLE | 91.2 | KG | 403460.935 | Peru | MIAMI LAKES | ASTRAZENECA UK LTD |
1/27/2022 | 3004902400 | MVASI 100MG / 4ML, AMGEN, S / M BOX X 1 VIAL MEDICINE FOR CONCENTRATED ONCOLOGICAL USE FOR INFUSION SOLUTION, 9007019, LOT: 1142883, EXPIRES: 30-APR-2024 BEVACIZUMAB 100MG / 4ML, INCOTERM DPU | 2.717 | KG | 13767.226 | Peru | SAN JUAN CAPISTRANO | AMGEN MANUFACTURING LTD |
1/27/2022 | 3004902400 | MVASI 400MG/16ML, AMGEN, S/M BOX X 1 VIAL MEDICINE FOR ONCOLOGICAL USE CONCENTRATED FOR SOLUTION FOR PERFUSION, 9006235, LOT: 1141001, EXPIRES: 31-MAR-2024 BEVACIZUMAB 400MG/16ML,INCOTERM DPU | 10.283 | KG | 52111.502 | Peru | SAN JUAN CAPISTRANO | AMGEN MANUFACTURING LTD |